Oxacyclotetradecane-2,4,10-trione,6-[[3,6-dideoxy-3-(dimethylamino)-b-D-glucopyranosyl]oxy]-14-ethyl-3,5,7,9,13-pentamethyl-,(3R,5R,6S,7S,9R,13R,14R)- (9CI) (102907-96-0)

Identification
Name:	Oxacyclotetradecane-2,4,10-trione,6-[[3,6-dideoxy-3-(dimethylamino)-b-D-glucopyranosyl]oxy]-14-ethyl-3,5,7,9,13-pentamethyl-,(3R,5R,6S,7S,9R,13R,14R)- (9CI)
Synonyms:	Picromycin,12-deoxy-10,11-dihydro-4'-hydroxy-, (4'S)-; Antibiotic Al-R 6-4; Kayamycin
CAS:	102907-96-0
Molecular Formula:	C28H49 N O8
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

Oxacyclotetradecane-2,4,10-trione,14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3R,5R,6S,7S,9R,13S,14R)-
Oxacyclotetradecane-2,4,10-trione,14-ethyl-6-hydroxy-5,7,9,11,13-pentamethyl-,(5R,6S,7S,9R,11R,13R,14R)-
Oxacyclotetradec-11-ene-2,4,10-trione,14-ethyl-13-hydroxy-3,5,7,9,13-pentamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3R,5R,6S,7S,9R,11E,13S,14R)-
(3R,5R,6S,7S,9R,11E,13R,14R)-14-ethyl-3,5,7,9,13-pentamethyl-2,4,10-trioxooxacyclotetradec-11-en-6-yl 3,4,6-trideoxy-3-(dimethylamino)hexopyranoside
(3R,5R,6S,7S,9R,11E,13R,14R)-3,5,7,9,13-Pentamethyl-6-hydroxy-14-ethyl-1-oxa-11-cyclotetradecene-2,4,10-trione
Oxacyclotetradecane-2,4,10-trione,14-ethyl-6,12-dihydroxy-5,7,9,11,13-pentamethyl-,(5R,6S,7S,9R,11R,12S,13R,14R)-
Oxacyclotetradecane-2,10-dione,4-[(4-O-acetyl-2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-xylo-hexopyranosyl)oxy]-12-(acetyloxy)-6-[(4,6-dideoxy-3-O-methyl-b-D-xylo-hexopyranosyl)oxy]-9-hydroxy-14-[(1S,2S)-2-hydroxy-1-methylpropyl]-3,5,7,9,11,13-hexamethyl-,(3R,4S,5R,6S,7S,9S,11R,12S,13S,14R)-
(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione; (2R,3S,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hexanoic acid
Oxacyclotetradecane-2,4,10-trione,14-ethyl-6,12-dihydroxy-5,7,9,13-tetramethyl-,(5R,6S,7S,9R,12R,13R,14R)-
Oxacyclotetradecane-2,6,10-trione,14-ethyl-4-hydroxy-5,7,9,11,13-pentamethyl-,(4R,5S,7S,9R,11R,13R,14R)-
Oxacyclotetradec-11-ene-2,4,10-trione,14-ethyl-6-hydroxy-5,7,9,11,13-pentamethyl-,(5R,6S,7S,9R,11E,13R,14R)-
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxy-furan-3-one, (3R,4S,5S, 6R,7R,9R,11R,12R,13R,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6 -methyl-oxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4R,5S,6S)-5-h ydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1 -oxacyclotetradecane-2,10-dione
Oxacyclotetradecane-2,10-dione,12-(acetyloxy)- 6-[(4,6-dideoxy-3-O-methyl-â-D-xylohexopyranosyl) oxy]-4,9-dihydroxy-14-[(1S,- 2S)-2-hydroxy-1-methylpropyl]-3,5,7,9,11,13- hexamethyl-,(3R,4S,5R,6S,7S,9S,11R,12S,13S,- 14R)-
Oxacyclotetradecane-2,4,10-trione,6-hydroxy-5,7,9,11,13,14-hexamethyl-, (5R,6S,7S,9R,11R,13R,14R)-
but-2-enedioic acid; (3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
Oxacyclotetradecane-2,4,10-trione,6,12-dihydroxy-5,7,9,13,14-pentamethyl-,(5R,6S,7S,9R,12R,13R,14R)-
Oxacyclotetradecane-2,10-dione,14-ethyl-4,6,12-trihydroxy-3,5,7,11,13-pentamethyl-,(3R,4S,5R,6S,7S,11R,12S,13R,14R)-
Oxacyclotetradecane-2,10-dione,14-ethyl-4,6,12-trihydroxy-3,5,7,9,11-pentamethyl-,(3R,4S,5R,6S,7S,9R,11R,12S,14R)-
Oxacyclotetradecane-2,6,10-trione,14-ethyl-4,12-dihydroxy-5,7,9,11,13-pentamethyl-,(4S,5S,7S,9R,11R,12S,13R,14R)-
Oxacyclotetradecane-2,6,10-trione,14-ethyl-4,12-dihydroxy-5,7,9,11,13-pentamethyl-,(4R,5S,7S,9R,11R,12S,13R,14R)-